Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 4.45M | $8.0M | 7.74% | -- | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 4.03M | $7.0M | 7.01% | -6.53M | 2026-06-30 |
| BlackRock, Inc. | 3.92M | $7.0M | 6.82% | +2.81M | 2026-06-30 |
| Vanguard Capital Management LLC | 2.13M | $3.0M | 3.70% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 1.96M | $3.0M | 3.42% | +318.6K | 2026-06-30 |
| Defilade Capital Management, L.P. | 1.67M | $3.0M | 2.92% | -- | 2026-06-30 |
| Dimensional Fund Advisors LP | 1.37M | $2.0M | 2.38% | +63.7K | 2026-06-30 |
| Geode Capital Management, LLC | 1.22M | $2.0M | 2.12% | +681.6K | 2026-06-30 |
| Connor, Clark & Lunn Investment Management Ltd. | 1.09M | $2.0M | 1.90% | +34.5K | 2026-06-30 |
| AWM Investment Company, Inc. | 1.00M | $1.0M | 1.74% | +475.0K | 2026-06-30 |
